DIALYSIS · CCN 392881

DaVita Harbison Dialysis

Philadelphia, PA 19149

DialysisProfitDaVita
$3.2M
TOTAL REVENUE
3.4%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.2M
Total costs
$3.1M
Operating income (rev − costs)
$108K
Operating margin
3.4%
Total charges
$3.3M
Total treatments
8,844
Dialysis stations
17

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8757—
Fistula Rate
DFC_FISTULA_RATE
67.270—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
025—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
248.946—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1970—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
12.4114—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
21.763—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
29.772—
Standardized ED Visits Ratio
DFC_SEDR
0.9721—